Zenith Drugs IPO Details | GMP, Date, Price, Review

Table of Contents

Zenith Drugs IPO Details ( Zenith Drugs Limited IPO Review )

(19 Feb 2024 – 22 Feb 2024)

Established in the year 2000, Zenith Drugs Limited is a pharmaceutical company focused on producing and trading top-notch, affordable medicines, including generic drugs.

We strictly adhere to the guidelines set by the World Health Organization (WHO-GMP) and have earned the ISO 9001:2015 certification from a reputable EuroUK certification body, showcasing our dedication to maintaining high quality.

Our product range includes:

  • ORS Powder
  • Liquid Orals
  • Ointments
  • Liquid Externals
  • Capsules

With approval from the Food & Drugs Administration, we currently have over 600 products, with 325 actively in production.

Excitingly, we’re in the process of establishing a new manufacturing facility in Village Muradpura, Depalpur, Indore, Madhya Pradesh.

We proudly supply our products to various countries, including Costa Rica in Central America, the Caribbean and Pacific regions, as well as Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan, Cambodia in Southeast Asia, Tajikistan, Liberia, Sierra Leone, and Conakry.

At Zenith Drugs Limited, we specialize in third-party manufacturing, also known as white label manufacturing, serving esteemed pharmaceutical companies like Ajanta Pharma, Bio Medical Laboratories, and Zest Pharma, among others.

As of March 31, 2023, our team consists of 89 employees, with 61 on payroll and 28 on contract.

Zenith Drugs Limited IPO Competitive Strength

  • Experienced Promoters and Management Team
  • Cost Efficiency
  • Formulations & Development
  • Regulatory Compliance
  • Global Reach
  • Product Portfolio
  • Supply Chain Efficiency
  • Scalable Business Model
  • Strong sales, marketing, and distribution capabilities

Zenith Drugs IPO Financials Performance ( Results )

Zenith Drugs Limited Financial Information (Restated Consolidated)

All Amount in ₹ Lakhs

Period EndedTotal AssetsTotal RevenuePATEPS
Net WorthNAV

Objective of Zenith Drugs IPO Issue

  • Purchase of Machinery & Equipments for Setting up New Unit
  • Existing Manufacturing Block Upgradation
  • Working Capital Requirements
  • General Corporate Purposes.

Zenith Drugs IPO Basic Details

IPO DateFeb 19, 2024 to Feb 22, 2024
Listing DateTuesday, February 27, 2024
Face Value₹10 per share
Price₹75 to ₹79 per share
Lot Size1600 Shares
Issue Size5,148,800 shares of ₹10
(aggregating up to ₹40.68 Cr)
Fresh Issue5,148,800 shares of ₹10
(aggregating up to ₹40.68 Cr)
Issue TypeBook Built Issue IPO
Listing AtNSE SME
Share holding pre issue12,000,000
Share holding post issue17,148,800
Company PromotersMr. Sandeep Bhardwaj,
Mr. Bhupesh Soni and
Mr. Ajay Singh Dassundi

Zenith Drugs IPO Reservation

QIB Shares Offered50% of the Net Issue
NII (HNI) Shares Offered15% of the Net Issue
Retail Shares Offered35% of the Net Issue

Zenith Drugs IPO Timetable

Zenith Drugs IPO will open on February 19, 2024 and close on February 22, 2024. You can join Zenith Drugs IPO at 10.00 A.M. to 5.00 p.m. Upto which mandate can be applied.

Opening Date19 February 2024 (Monday)
Closing Date22 February 2024 (Thursday)
Basis of Allotment23 February 2024 (Friday)
Initiation of Refunds26 February 2024 (Monday)
Credit of Shares to Demat26 February 2024 (Monday)
Listing Date27 February 2024 (Tuesday)
Deadline for UPI mandate confirmation5 PM on 22 February 2024

Zenith Drugs IPO Lot Size

For retail investors in Zenith Drugs IPO, 1600 shares will come in 1 lot or the minimum investment will be ₹126,400. Retail-individual investors can apply for up to 1 lots or the maximum investment will be ₹126,400.

Retail (Min)11600₹126,400
Retail (Max)11600₹126,400
S-HNI (Min)23200₹252,800

Zenith Drugs IPO Promoter Holding

The company’s promoters include Mr. Sandeep Bhardwaj, Mr. Bhupesh Soni and Mr. Ajay Singh Dassundi.

Pre Issue Share Holding100.00%
Post Issue Share Holding69.98%

Zenith Drugs Ltd IPO Key Performance Indicator ( Valuation )

In the table given below, all the figures have been told according to the latest financial year.

Market Cap (₹ Cr.)135.48
Earning Per Share (EPS)₹4.29 per Equity Share
Net Asset Value (NAV)₹14.37 per Equity Share
P/E Ratio (P/E) (x)18.40
Post P/E Ratio (P/E) (x)12.56
Return on Net Worth (RoNW) (%)29.88
Return on equity (ROE) (%)35.13
Return on Capital Employed (ROCE) (%)37.29
Debt/Equity Ratio1.51
Price/Book Value Ratio5.50

Zenith Drugs Ltd Peer Comparison

Company NameConsolidated/
Zenith Drugs LimitedConsolidated79.0010.004.2918.4029.88
Peer Group
Sudarshan Pharma
Industries Limited
Sigachi Industries

Zenith Drugs IPO GMP Live Update, Kostak Rate day by day

DateGMPKostakSubject to
16 February 2024₹7
15 February 2024₹6

Zenith Drugs IPO Detail Video:


Zenith Drugs IPO Subscription Status (Bidding Detail)

The Zenith Drugs IPO on February 22, 2024 at 7:30:00 PM was subscribed 179.18 times, with the retail category being subscribed 139.28 times, the NII (Non-Institutional Investor) category being subscribed 368.77 times, QIB (Qualified-Institutional Buyers) category being subscribed 106.72 times.


Zenith Drugs IPO Prospectus

Zenith Drugs IPO DRHPDownload
Zenith Drugs IPO RHPDownload
Zenith Drugs IPO Anchor Investors Details PDFDownload

Zenith Drugs IPO Rating

Our Rating2.0/5.0

Zenith Drugs Company Contact Information

Zenith Drugs Limited

Zenith Drugs Limited

Registered Office: K. No. 72/5, Village Muradpura, NA, Depalpur, Indore-453001, Madhya Pradesh, India.
Contact Person: Ms. Sakshi Bhawsar: Company Secretary and Compliance Officer
Email Id: info@zenithdrugs.com
Tel No: +91 8435501867
Website: www.zenithdrugs.com
Our Promoters: Mr. Sandeep Bhardwaj, Mr. Bhupesh Soni and Mr. Ajay Singh Dassundi

Zenith Drugs IPO Registrar

Bigshare Services Private Limited

Registered Office: S6-2, 6th Pinnacle Business Park, Mahakali Caves Road, next to Ahura Centre, Andheri East, Mumbai- 400093, Maharashtra, India
Tel No.: +91 – 22 – 6263 8200; Fax No.: +91 – 22 – 6263 8299
E-mail: ipo@bigshareonline.com
Investor Grievance E-mail: investor@bigshareonline.com
Website: www.bigshareonline.com
Contact Person: Mr. Asif Sayyed
SEBI Registration No.: INR000001385

Zenith Drugs IPO Lead Manager

Gretex Corporate Services Limited

Registered Office: Office No. 13, 1st Floor, New Bansilal Building, Raja Bahadur Mansion, 9-15, Homi Modi
Street, Fort, Mumbai– 400001, Maharashtra, India.
Tel No.: +91 96532 49863
Email: info@gretexgroup.com
Website: www.gretexcorporate.com
Contact Person: Ms. Dimple Magharam Slun
SEBI Registration No: INM000012177
CIN: L74999MH2008PLC288128

Zenith Drugs IPO FAQs

What is the lot size of Zenith Drugs IPO?

The total size of Zenith Drugs IPO is ₹40.68 crores and this is a complete fresh Issue.

When will Zenith Drugs IPO start?

Zenith Drugs IPO will open from 19 February 2024 and IPO will close on 22 February 2024.

What is the open date of Zenith Drugs IPO?

Zenith Drugs IPO will open date from 19 February 2024.

What is the last date ( close date ) of Zenith Drugs IPO?

Zenith Drugs IPO will close from 22 February 2024.

What is the price band of Zenith Drugs IPO?

Zenith Drugs IPO price band is ₹75 to ₹79. ( Upper Price Band: ₹79, Lower Price Band: ₹75 )

What is the minimum amount required to apply for Zenith Drugs IPO?

The minimum investment for retailers to apply for Zenith Drugs IPO is ₹126,400 and the maximum investment is ₹126,400.

What is going on gray market premium of Zenith Drugs IPO?

View gray market premium of Zenith Drugs  IPO by Clicking Here

How much is the GMP of Zenith Drugs IPO?

Watch Zenith Drugs IPO GMP Today: Click Here

What is the allotment date of Zenith Drugs IPO?

The allotment date of Zenith Drugs IPO is 23 February 2024.

How to check allotment status in Zenith Drugs IPO?

To check the allotment status of Zenith Drugs IPO, first of all go to the registrar website by clicking here, select your bad Zenith Drugs IPO name or enter your bad application number, PAN number or client ID and click on submit. ( Video Link )

What is the listing date of Zenith Drugs IPO?

The listing date of Zenith Drugs IPO is 27 February 2024.

How much will be the listing gain in Zenith Drugs IPO?

View listing gain of Zenith Drugs IPO by Clicking Here

How much time Zenith Drugs IPO is subscribed?

Total 179.18 times subscribed in Zenith Drugs IPO out of which 139.28 times subscription was done in retail quota, 368.77 times subscription in NII quota and 106.72 times subscription in QIB quota.

How to apply for Zenith Drugs IPO from Upstox?

Click Here to see how to apply for Zenith Drugs IPO from Upstox. (step by step)

How to apply for Zenith Drugs PO from Zerodha?

Click Here to see how to apply for Zenith Drugs IPO from Zerodha. (step by step)

How to apply for Zenith Drugs IPO from Angle One?

Click Here to see how to apply for Zenith Drugs IPO from Angle One. (step by step)

Leave a Reply

Your email address will not be published. Required fields are marked *